 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 7, 1093-1106, Copyright © 1987 by Society for Neuroscience
Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity
PE Sawchenko
Following adrenalectomy (ADX), corticotropin-releasing factor (CRF) and
vasopressin immunoreactivity are jointly expressed by a population of
parvocellular neurosecretory neurons in the paraventricular nucleus of the
hypothalamus (PVH). Because these cells stain positively for CRF, but not
for vasopressin, after pretreatment with colchicine, the results suggest
the existence of state-dependent alterations in the expression of peptides
by neuroendocrine neurons. The present study sought to determine whether
other neuropeptides (e.g., neurotensin, met- enkephalin) that have been
colocalized with CRF in the parvocellular division of the PVH are
influenced similarly by ADX; whether the enhancement of CRF and/or
vasopressin immunoreactivity after ADX is limited to neurons of the PVH;
and what factors might be involved in the regulation of the expression of
these peptides in the PVH. The results confirmed that CRF and vasopressin
immunoreactivity are both enhanced, and may be colocalized in a substantial
population of parvocellular neurosecretory neurons after ADX; no comparable
enhancement of staining for met-enkephalin or neurotensin was observed. The
effect of ADX on CRF immunoreactivity was not limited to cells in the PVH,
as neurons in the cerebral cortex, amygdala, and the bed nucleus of the
stria terminalis also showed heightened CRF immunostaining after ADX;
vasopressin immunoreactivity was never colocalized with CRF in these
extrahypothalamic sites. Hypophysectomy produced an enhancement of CRF and
vasopressin staining in the PVH that was comparable to that seen after ADX,
implicating adrenal steroids as primary regulators of peptide expression in
this system. Corticosteroid replacement studies in ADX rats indicated that
lower doses of dexamethasone attenuated, and higher doses essentially
abolished, the expected enhancement of both CRF and vasopressin
immunoreactivity after ADX. The relative potency of steroids in mitigating
these effects was dexamethasone greater than corticosterone greater than
deoxycorticosterone greater than aldosterone. Collectively, these results
indicate that the ADX-induced enhancement of CRF and vasopressin
immunoreactivity in parvocellular neurosecretory neurons is at least
somewhat specific to these peptides and to this cell type. Both peptides
would appear to be regulated similarly by adrenal steroids, with
glucocorticoids playing a primary role.
This article has been cited by other articles:

|
 |

|
 |
 
A. S. Lalmansingh and R. M. Uht
Estradiol Regulates Corticotropin-Releasing Hormone Gene (crh) Expression in a Rapid and Phasic Manner that Parallels Estrogen Receptor-{alpha} and - Recruitment to a 3',5'-Cyclic Adenosine 5'-Monophosphate Regulatory Region of the Proximal crh Promoter
Endocrinology,
January 1, 2008;
149(1):
346 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hori, N. Yuyama, and K. Tamura
Biting Suppresses Stress-induced Expression of Corticotropin-releasing Factor (CRF) in the Rat Hypothalamus
J. Dent. Res.,
February 1, 2004;
83(2):
124 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gomez, S. Manalo, and M. F. Dallman
Androgen-Sensitive Changes in Regulation of Restraint-Induced Adrenocorticotropin Secretion between Early and Late Puberty in Male Rats
Endocrinology,
January 1, 2004;
145(1):
59 - 70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kuwahara, H. Arima, R. Banno, I. Sato, N. Kondo, and Y. Oiso
Regulation of Vasopressin Gene Expression by cAMP and Glucocorticoids in Parvocellular Neurons of the Paraventricular Nucleus in Rat Hypothalamic Organotypic Cultures
J. Neurosci.,
November 12, 2003;
23(32):
10231 - 10237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Verkuyl and M. Joels
Effect of Adrenalectomy on Miniature Inhibitory Postsynaptic Currents in the Paraventricular Nucleus of the Hypothalamus
J Neurophysiol,
January 1, 2003;
89(1):
237 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Laugero, F. Gomez, S. Manalo, and M. F. Dallman
Corticosterone Infused Intracerebroventricularly Inhibits Energy Storage and Stimulates the Hypothalamo-Pituitary Axis in Adrenalectomized Rats Drinking Sucrose
Endocrinology,
December 1, 2002;
143(12):
4552 - 4562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Haluzik, K. R. Dietz, J. K. Kim, B. Marcus-Samuels, G. I. Shulman, O. Gavrilova, and M. L. Reitman
Adrenalectomy Improves Diabetes in A-ZIP/F-1 Lipoatrophic Mice by Increasing Both Liver and Muscle Insulin Sensitivity
Diabetes,
July 1, 2002;
51(7):
2113 - 2118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. McEwen
Genome and Hormones: Gender Differences in Physiology: Invited Review: Estrogens effects on the brain: multiple sites and molecular mechanisms
J Appl Physiol,
December 1, 2001;
91(6):
2785 - 2801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Laugero, M. E. Bell, S. Bhatnagar, L. Soriano, and M. F. Dallman
Sucrose Ingestion Normalizes Central Expression of Corticotropin-Releasing-Factor Messenger Ribonucleic Acid and Energy Balance in Adrenalectomized Rats: A Glucocorticoid-Metabolic-Brain Axis?
Endocrinology,
July 1, 2001;
142(7):
2796 - 2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. MacNeil, A. H. Jansen, A. H. Greenberg, and D. M. Nance
Effect of acute adrenalectomy on sympathetic responses to peripheral lipopolysaccharide or central PGE2
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2000;
278(5):
R1321 - R1328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen and Q. J. Pittman
Vasopressin and Amastatin Induce V1-Receptor-Mediated Suppression of Excitatory Transmission in the Rat Parabrachial Nucleus
J Neurophysiol,
October 1, 1999;
82(4):
1689 - 1696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. McEwen and S. E. Alves
Estrogen Actions in the Central Nervous System
Endocr. Rev.,
June 1, 1999;
20(3):
279 - 307.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Jang and D. R. Romsos
Neuropeptide Y and Corticotropin-Releasing Hormone Concentrations within Specific Hypothalamic Regions of Lean but Not Ob/ob Mice Respond to Food-Deprivation and Refeeding
J. Nutr.,
December 1, 1998;
128(12):
2520 - 2525.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen
Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution
J. Clin. Endocrinol. Metab.,
March 1, 1998;
83(3):
736 - 743.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Rabadan-Diehl, G. Makara, A. Kiss, S. Lolait, D. Zelena, T. Ochedalski, and G. Aguilera
Regulation of Pituitary V1b Vasopressin Receptor Messenger Ribonucleic Acid by Adrenalectomy and Glucocorticoid Administration
Endocrinology,
December 1, 1997;
138(12):
5189 - 5194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Iwasaki, Y. Oiso, H. Saito, and J. A. Majzoub
Positive and Negative Regulation of the Rat Vasopressin Gene Promoter
Endocrinology,
December 1, 1997;
138(12):
5266 - 5274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Liu, J. Diorio, B. Tannenbaum, C. Caldji, D. Francis, A. Freedman, S. Sharma, D. Pearson, P. M. Plotsky, and M. J. Meaney
Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress
Science,
September 12, 1997;
277(5332):
1659 - 1662.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. K. Patchev and O. F. X. Almeida
Gonadal Steroids Exert Facilitating and ``Buffering'' Effects on Glucocorticoid-Mediated Transcriptional Regulation of Corticotropin-Releasing Hormone and Corticosteroid Receptor Genes in Rat Brain
J. Neurosci.,
November 1, 1996;
16(21):
7077 - 7084.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|